Cancer News and Research

Latest Cancer News and Research

Six factors independently predicted melanoma risk

Melanoma, the most serious form of skin cancer, is a health risk that accounts for more than 75 percent of all skin cancer deaths, according to the American Cancer Society (ACS).

5 Mar 2009

Better understanding of how stem cells develop into blood cells

How messages sent within stem cells through a specific communication pathway can trigger the cells to specialize and become blood cells in humans, has been discovered by scientists of the McMaster Stem Cell and Cancer Research Institute.

5 Mar 2009

Scientists make a strain of E. coli glow under fluorescent light

A team of Michigan Technological University researchers led by Associate Professor of Chemistry Haiying Liu has discovered how to make a strain of E. coli glow under fluorescent light.

5 Mar 2009

European Commission and US FDA approve intravenous formulation of temozolomide

Schering-Plough Corporation (NYSE:SGP) today announced that the European Commission and the US FDA both approved the intravenous (IV) formulation of temozolomide as an alternative to the already approved oral form of the drug.

5 Mar 2009

Breakthrough produces Parkinson's patient-specific stem cells free of harmful reprogramming genes

Deploying a method that removes potentially cancer-causing genes, Whitehead Institute researchers have "reprogrammed" human skin cells from Parkinson's disease patients into an embryonic-stem-cell-like state.

5 Mar 2009

Brain tumor treatment may increase number of cancer stem-like cells

A new study suggests that the standard treatment for a common brain tumor increases the aggressiveness of surviving cancer cells, possibly leaving patients more vulnerable to tumor recurrence.

5 Mar 2009

Obama hosts health care summit at White House

A White House health care summit hosted on Thursday by President Obama will enable attendees to discuss reform proposals for the U.S. health care system, the AP/Philadelphia Inquirer reports (Alonso-Zaldivar, AP/Philadelphia Inquirer, 3/5).

5 Mar 2009

HIV/AIDS advocates in Thailand urge government to maintain compulsory license program

HIV/AIDS advocates in Thailand plan to meet with officials to urge the government not to restrict its compulsory license program, which allows people in the country to access low-cost, generic versions of drugs such as antiretroviral medications, AFP/Google.com reports.

5 Mar 2009

Launch of new cancer equipment

A new piece of equipment which has been installed at the University of Hertfordshire to train radiotherapy students to treat cancer patients will be launched at a Science and Engineering Week event on Tuesday (10th March).

5 Mar 2009

Patented inventions double at University at Buffalo

An antibody with the potential to stop breast cancer in its path. A nanoparticle that can address a side effect of the treatment that hemophiliacs cannot live without. A "quantum dot" with the potential to treat cancer or harvest the power of the sun. An air purifier that kills the world's nastiest toxins.

5 Mar 2009

Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment

New research out of Wake Forest University School of Medicine identifies the presence of cardiovascular risk factors as an indicator of how likely it is that elderly, hospitalized patients who receive intravenous immunoglobulin (IVIg) treatment will have a stroke or heart attack.

5 Mar 2009

Stereotactic body radiotherapy doubles survival in lung cancer

Countless people have heard the phrase, "You have lung cancer," but only 50 can say they've completed a new treatment at Temple University that doubles their chances of surviving the deadly disease - and without the conventional radiation regimen or surgery.

4 Mar 2009

Stem cells could halt osteoporosis, promote bone growth

While interferon gamma sounds like an outer space weapon, it's actually a hormone produced by our own bodies, and it holds great promise to repair bones affected by osteoporosis.

4 Mar 2009

RNA World: a new frontier in biomedical research

Research into RNA, a molecule found in every cell of our bodies, could lead to remarkable advances in the treatment of diseases such as cancer and diabetes, a meeting organised by the European Science Foundation was told.

4 Mar 2009

New microgel capsules trap omega-3 fatty acids

Nutritionists are nearly unanimous in recommending that Americans should eat significantly more omega-3 fatty acids and consume them in foods, not in vitamin pills.

4 Mar 2009

Naked mole rats may hold clues to successful aging

Naked mole rats resemble pink, wrinkly, saber-toothed sausages and would never win a beauty contest, even among other rodents.

4 Mar 2009

Pretreatment MRI and PET/CT for cervical cancer improves chances for optimal treatment

Pretreatment MRI and PET/CT for cervical cancer may direct more women to optimal therapy choices and spare many women potential long-term morbidity and complications of trimodality therapy (surgery followed by chemoradiation), according to a study performed at the Institute for Technology Assessment in Boston, MA.

4 Mar 2009

Daily naps may not be that good for older women

A new study appearing in Journal of the American Geriatrics Society has found that older women who reported taking daily naps had a significantly greater risk of dying.

4 Mar 2009

Hypertension linked to earlier death among African-American breast cancer patients

A study by researchers at the University of California, San Francisco has shown that hypertension, or high blood pressure, is a predictor of mortality among breast cancer patients, especially those who are African-American, and that hypertension accounts for approximately 30 percent of the survival disparity between African-American and white breast cancer patients.

4 Mar 2009

FDA accepts IND application for Tigris Pharmaceutical's GGTI-2418

Tigris Pharmaceuticals, Inc., has announced that its Investigational New Drug (IND) application for the Company's geranylgeranyltransferase inhibitor (GGTI-2418) has been accepted by the U.S. Food and Drug Administration.

4 Mar 2009